Browsing Tag
acute ischemic stroke
3 posts
Could THUNDERBOLT sharpen Penumbra’s stroke portfolio before the Boston Scientific deal closes?
Find out how Penumbra’s THUNDERBOLT FDA clearance could reshape stroke thrombectomy and computer assisted clot removal.
June 12, 2026
Lumosa Therapeutics reports Phase 2 functional gains for LT3001 in disabling acute ischemic stroke
Lumosa Therapeutics’ LT3001 Phase 2 stroke data show functional gains beyond standard windows. Find out what this means for Phase 3 and investors.
February 8, 2026
BRILINTA FDA approval: A major step in reducing stroke risks in acute ischemic stroke and high-risk TIA patients
AstraZeneca has secured U.S. Food and Drug Administration (FDA) approval for BRILINTA (ticagrelor), expanding its use to reduce…
November 8, 2020